We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High Apolipoprotein Linked to Kidney Disease

By Biotechdaily staff writers
Posted on 22 Jan 2006
Researchers have found that elevated levels of the serum protein apolipoprotein A-IV (apo A-IV) may serve as a biomarker for increased risk of development and progression of kidney disease.

Investigators at Innsbruck Medical University (Austria) worked over a seven-year period with a group of 177 non-diabetic patients with primary kidney disease classified as mild to moderate. More...
Each patient's lipid and apolipoprotein profiles were monitored on a regular basis. Determination of glomerular filtration rate was used to assess kidney function.

Results published in the December 28, 2005, online edition of the Journal of the American Society of Nephrology revealed that of all the parameters measured, only the apoA-IV level was significantly related to deterioration in kidney function. The average time to progressive kidney disease was 54 months for patients with apoA-IV levels above the median, compared to 70 months for those with lower apoA-IV levels.

Senior author Dr. Florian Kronenberg, professor of medial genetics at Innsbruck Medical University, said. "Our results show that apoA-IV is an excellent predictor for the progression of kidney disease, adding important and additional information besides the exact determination of kidney function. It therefore seems that apoA-IV is not only an early marker of renal impairment, but also predicts whether the kidney function will worsen during the upcoming years.”




Related Links:
Innsbruck Medical University \

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.